Cure My Disease

Don't miss your cure!

 Log in / Sign up

New identity skills training aims to ease borderline personality disorder symptoms

NCT ID NCT07684872

Symptom relief Sponsor: Universidad Europea de Valencia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This trial investigates whether a psychological program called DBT-LIVE, which focuses on identity disturbance, can help people with borderline personality disorder (BPD). Around 112 participants will be randomly assigned to receive either DBT-LIVE or their usual treatment. Researchers will measure changes in identity confusion, emotional regulation, self-compassion, and suicidal behavior over six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
DBT-LIVE identity skills training program
What this could lead to
If effective, this program could offer a new, targeted psychological treatment to help people with BPD strengthen their sense of self and manage emotions better.
What could go wrong
This is a relatively small, early-stage trial comparing the program to usual treatment. Results may not apply broadly, and the program may not prove more helpful than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 112 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2027

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being 16 years old or more. * Having the diagnosis of Borderline Personality Disorder. * Currently receiving treatment or follow-up care at the recruitment center mentioned above. * Signing the informed consent form to participate in the study; in the case of minors, consent must be provided by parents or legal guardians. Exclusion Criteria: * Individuals with severe conditions that may interfere with participation in the research-such as psychosis, schizophrenia, or intellectual disability. * Individuals with high substance use who are not in optimal condition to follow the treatment program. * Individuals who present an imminent risk of suicide or who are not in adequate psychological condition to participate in the program.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Treatment 1:dialectical behavior therapy (DBT) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

borderline personality disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Treatment 1:dialectical behavior therapy (DBT) Treatment as usual

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Valencia

    Valencia, Valencia, 46010, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.